Skip to content
Home/Companies/Healthcare/Enyo Pharma
EP

Enyo Pharma

Healthcare·France·Active·8yr hold

Enyo Pharma is a healthcare company, headquartered in France.

Entry
2018
Hold
8yr
Status
Active
Est. EV
–

Who owns Enyo Pharma?

Enyo Pharma is currently owned by Andera Partners through BioDiscovery 5 (2017 vintage), since 2018. Across its history, Enyo Pharma has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Andera Partners
Most recent investor
Andera Partners
BioDiscovery 5 · 2017 · VC
3 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by Bpifrance Investissement, Sofinnova Partners and Andera Partners since 2016.
Co-invest · 3 holders · 2016 · present
Bpifrance Investissement
Bpifrance InvestissementActive
2016 · present · Large Venture · 2013 · Growth
MOIC
–
Sofinnova Partners
Sofinnova PartnersActive
2016 · present · Sofinnova Capital VIII · 2015 · Life Sciences VC
MOIC
–
Andera Partners
Andera PartnersActive
2018 · present · BioDiscovery 5 · 2017 · VC
MOIC
–

More from BioDiscovery 5

Other portfolio companies in the same fund.

Amolyt Pharma
Exited 2024
HealthcareFrance· 2021
to
Evommune
Exited 2025
HealthcareFrance· 2021
to
Nyxoah
Active
HealthcareBelgium· 2020
AgoMab
Exited 2026
HealthcareFrance· 2019
to
AM Pharma
Active
HealthcareNetherlands· 2019
Arvelle
Exited 2021
HealthcareSwitzerland· 2019
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings